BRC News

The event highlighted the crucial role of CRPs in the NHS and how NHS employers can develop their CRP workforce.

A large-scale study from UCLH and UCL highlights the real-world impact of life after stroke, revealing the significant burden faced by survivors.

Researchers have found a way to predict when children with arthritis may have painful flare-ups in their joints.

Host a stall at UCLH’s Celebrating Research Open Day on 3 July 2025 – an interactive event showcasing innovation, clinical trials, and cutting-edge healthcare advancements.

Prof Paola Giunti helped deliver the first-ever treatment for the rare neurodegenerative disease Friedrich’s ataxia.

Researchers have developed a groundbreaking, minimally invasive treatment that could offer hope for millions of people with a form of high blood pressure caused by a commonly overlooked condition.

A personalised intervention for hearing care could help protect cognitive health in older adults at risk of dementia, according to a pilot study from UCLH and UCL.

On World Cancer Day, we explore how UCLH is expanding its research into cell therapies for solid tumours.

UCLH has recruited the first participant to an international trial in frontotemporal dementia, one of the most common causes of early-onset dementia.

A new study at UCLH and UCL aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.

Subtle changes in the brain happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study has found.

Members of the public can now join a registry of healthy volunteers willing to be contacted about taking part in health research.

Researchers at UCLH, the Francis Crick Institute, and the UCL Cancer Institute have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors.

The newsletter from the NIHR UCLH Clinical Research Facility looks back on 2024.

A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.